Brief statements: The significant finding of this study is that the atomic bomb survivors who had been exposed at a younger age still have a higher risk for a wide range of cancers, even at 62 years after the bombing. These results, on the associations between incidence of multiple primary cancers and atomic bombing, are described for the first time in this report.
Summary
To assess effects of atomic bomb radiation on incidence of multiple primary cancers (MPC), we analyzed the association between incidence of second primary cancers in the survivors of the atomic bombing of Nagasaki and exposure distance. The incidence rate (IR) of a second primary in MPC was calculated and stratified by the distance from the hypocenter and age at the time of bomb for the years 1968 through 1999. The IR of first primary was also calculated and compared with second primary to determine whether atomic bomb radiation was associated with the multiplicity of the tumors. There were 511 confirmed cases of MPC in the 7,572 cancer-bearing survivors. The crude IR was 27.6 per 100,000 person-years. The IR of second primaries significantly decreased with increasing distance from the hypocenter: relative risk (RR), 0.89 per 1.0 km; 95% confidence interval (CI), 0.84-0.94. A significant decrease was also noted for those of older ages at the time of the bombing based on the attained age of second primary: RR,
Introduction
Sixty-two years have now elapsed since two atomic bombs were exploded on Hiroshima and Nagasaki, Japan on August 6 and 9, 1945. The average age of the survivors has now reached 75 years. Several types of leukemia showed the highest incidence in the 5 to 10 year period after the atomic bomb explosions. Meanwhile, an increased risk of cancers has continued for decades, and the incidences of certain types of cancers are still higher than in controlled populations. (1) (2) (3) The occurrence of multiple primary cancers (MPC) is considered to be a reflection of systematic exposure to environmental carcinogens or of a predisposition to cancer. The association of radiation exposure from the atomic bomb and the development of MPC has not yet been studied, but is of interest in terms of learning more about the effects of whole-body irradiation on carcinogenesis. To elucidate the late carcinogenic effects of atomic bomb radiation on the survivors, the association between the incidence of MPC in survivors and exposure distance from the hypocenter has been analyzed. This study was conducted to provide insights into the etiology of cancer among the survivors and also to collect important information for medical care of the atomic bomb survivors and other victims of radiation-associated accidents around the world.
Subjects and Methods

Subjects
A series of clinical data were available on 91,890 subjects including 54,915 females and 36,975 males of the survivors registered at the Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, which was established in 1972. The registry of clinical data on Nagasaki survivors was started in 1968. This population was confined to residents in Nagasaki city who were directly exposed by the atomic bomb and used as a denominator. A survivor was defined in the present study as a person who received the "Atomic Bomb Survivor's Health Handbook" produced by Nagasaki city authorities since the establishment of the Atomic Bomb Survivors' Medical Treatment Law in April 1957. All information including exposure distance had been recorded before this study.
To examine malignancy cases in survivors, we used a database by the Nagasaki Tumor Tissue Registries (NTTR), which was established in 1974. This data base included 301,673 cases of tissue registration based on pathological reports of patients living in south Nagasaki prefecture including Nagasaki city since 1961 through 1999.
The registered database included patient age, gender, tumor site, histological diagnosis, and date of diagnosis. These data were linked to the survivors' database since 1968 to identify survivors having suffered from malignancy. The experimental protocol was approved by the Ethics Review Committee of Nagasaki University Graduate School of Biomedical Sciences (Protocol No. 0305150036). Nakashima et al.
To identify MPC in atomic bomb survivors
A retrospective search of the database for MPC was conducted according to following criteria: i) multiple (two or more) primaries occurring in different organs, ii) multiple lesions of different histological types occurring in paired organs but apparently different sites (e.g. adenocarcinoma of left lung and small cell carcinoma of right lung, ductal carcinoma of left breast and lobular carcinoma of right breast), iii) multiple lesions of the same histological type occurring in paired organs are not counted as a MPC but as a single primary, iv) multiple primaries occurring in the colorectum but apparently different sites (e.g. ascending and sigmoid colon). A series of immunohistochemical studies were used with site-related antibodies, including cytokeratins 7 and 20, thyroid transcription factor-1, CA125, prostate specific antigen, estrogen receptor, progesterone receptor, etc., to carefully differentiate primary or metastatic cancers (e.g. colorectal and lung cancers, colon/gastric cancer and ovarian cancers, prostatic/uterine and rectal cancers).
To evaluate the association between MPC and atomic bomb radiation
In this study, an event of MPC in each survivor was considered to occur with a pathological diagnosis of two first primaries in synchronous case/second primary in metachronous case. Person-years of observation were cumulative from the date when the individual survivor's data was registered in our database until the earliest date at diagnosis of two first primaries in a synchronous case/second primary in a metachronous case, date of death, the end of follow-up (date when survivors moved outside of Nagasaki city), or the end of study (31 December 1999). Then, the incidence rate (IR) of MPC per 100,000 person-years among atomic bomb survivors including healthy individuals was calculated by stratification of the distance from the hypocenter (0-1.0, 1.1-1.5, 1.6-2.0, 2.1-2.5, 2.6-3.0, >3.0km) and age at the time of bombing (0-9, 10-19, 20-29, 30-39, ≥40). Furthermore, the IR of second primaries per 100,000
person-years among atomic bomb survivors who had experienced the first primary was calculated exactly in the same way as mentioned above, and compared with the IR of first primaries to clarify whether atomic bomb radiation was associated with the multiplicity of tumors.
The exposure distance was used as a substitute for the estimated irradiated dose.
Actually, several unique epidemiological studies on Nagasaki survivors have already been documented with exposure distances. (4) (5) (6) (7) (8) (9) In general, survivors who were less than 1.5 km from the hypocenter were exposed to a significant dose of radiation. The estimated doses in Nagasaki survivors who were not shielded at the time of explosion are: 924.7 cGy at 1.0 km, 120.7 cGy at 1.5 km, 17.9 cGy at 2.0 km, and 2.9 cGy at 2.5 km from the hypocenter. 
Statistical analyses
The effects of change in exposure distance, age at the time of bombing, and gender on the IR of second/first primary in survivors was evaluated using a Cox proportional hazard model. The Cox model is a robust, semiparametric method for modeling time-to-event data in the presence of censored cases to assess the effect of independent predictor variables. The following predictor variables were used in the model: exposure distance, age at the time of bombing, and gender. An event was considered to occur with the development of second/first primary. A comparison of IR between the two groups (younger vs. older attained age-range, first vs. second primary) was performed by the relative risk (RR) with 95% confidence interval (CI). The PHREG procedure in the SAS 8.2 software (SAS Institute, Cary, NC, USA) was utilized for calculation. All tests were two tailed, and a p-value of <0.05 was considered statistically significant. Table 2. MPC can be divided into synchronous and metachronous groups depending on the interval between their diagnoses. The MPC cases determined by the interval between the first and second primaries are summarized in Table 3 . Of the 511 MPC cases, 331 cases (64.8%) had two primaries within the 5-year interval (short-term). Of these, there were 82 synchronous cases (16.0%) and 249 short-term metachronous cases (48.8%).
Results
The
The IRs of short-term MPC by the exposure distance and age at the time of bombing were also calculated. The IR of short-term MPC significantly decreased with increased Associations between the IR of second primary in metachronous cases and exposure distance/age at the time of bombing/gender, and their comparisons with first primary
In our cohort, 7,572 survivors were found who had suffered from a malignancy.
Overall 7,572 survivors bearing a first primary were followed for 193,274 person-years during which a total of 429 second primary cases (in which 82 synchronous cases were excluded) that included 217 females and 212 males were confirmed. The crude IR of second primaries was 222.0 per 100,000 person-years in the survivors bearing first primary, whereas that of a first primary was 419.0 per 100,000 person-years in the overall study population ( Table 4 ). The IRs of second and first primaries categorized by gender and exposure distance are presented in Table 4 (Table 5) . By compariing overall RR per 1.0km increment between the second and first primary, a stronger distance effect was suggested on the occurrence of second primary.
Simultaneously, an age effect was observed in the IRs of both second and first primary, (Table 5 ). However, contrary to that in the overall population, in the younger attained-age group less than 50-yo, the IRs of both second and first primaries were higher in females than in males [RR vs. male: 2.50 and 1.53, 95% CI: 0.80-7.87 and 1.31-1.79, respectively] ( Table 5) .
Sites of second and first primary
A wide range of cancers was observed in both second and first primaries. Sites of second primary (in which 82 synchronous cases were excluded) by gender and attained-age are presented in Table 6 . The most prominent sites for second primary included the breast and lung (n=3, 21.4%, each) in younger attained-age group (n=14), while colon (n=84, 20.2%) and stomach (n=80, 19.3%) were followed by lung (n=50, 12.0%) in the older attained-age group (n=415). The most prominent sites for first primary included the stomach (n=162, 23.1%) following breast (n=121, 17.3%) and uterine cervix (n=111, 15.9%) in the younger attained-age group (n=700), while stomach (n=1713, 25.2%) and colon (n=917, 13.5%) were in the older attained-age group (n=6790).
DISCUSSION
In general, the population-based systematic studies on the incidence of MPC have been carried out by long standing cancer registries, because a huge cohort of cancer patients has to be followed to identify MPC cases. However, a previous report showed a modification of the risk of developing MPC in cancer patients in comparison with the general population. (10) The cohort studied showed an approximately 10% reduced risk of developing further cancers in comparison with the general population when only second metachronous cancers were considered. In contrast, the inclusion of synchronous cases resulted in an approximately 10% increased risk. MPC is defined as two or more independent primary cancers arising in the same individual, and their existence of does not depend on time. Therefore, synchronous MPC should be included in a study on MPC incidence, and could be diagnosed not only in cancer patients but could also be present in cancer-free patients before the diagnosis. We carefully reviewed each case with a series of immunohistochemistry to determine whether each malignancy is primary or metastatic and, finally, identified 82 synchronous cases (16.0%) from a total 511 MPC in Nagasaki survivors who suffered direct exposure.
Because the main purpose of this study was to clarify the significance of atomic bomb radiation on the multiplicity of tumors, we could not exclude these synchronous cases in calculating the IR of MPC among overall survivors. Simultaneously, the IR of a second primary, excluding synchronous cases among survivors who had experienced a first primary, was calculated. This IR was then compared with that of the first primary to determine whether atomic bomb radiation was associated with the multiplicity of the tumors. This study points out the significance of atomic bomb radiation on the occurrence of MPC in the survivors. Furthermore, compared with first primary, the higher increased risk for the development of a second primary was noted in the survivors who were exposed at a closer distance, again suggesting the association of atomic bomb radiation on the occurrence of MPC. These results dealing with the incidence of MPC and its associations with the atomic bombing of 62 years ago are described for the first time in this report.
In a previous Japanese report, the incidence of MPC in Nagasaki survivors was examined with cases registered at the NTTR during the period from 1973-1977. (4) These cases should be a part of the cohort in our present study, but no significance of atomic bomb radiation exposure in the incidence of MPC was found in those Nagasaki survivors. (4) The increased risk for MPC seems to begin more recently than that for single cancers. It is quite plausible that the survivors who had been exposed at younger ages have already reached the cancer-prone age to develop the cancers in multiple organs. Thus, the atomic bombing of 62 years ago is still increasing the cancer risks in survivors, particularly for those exposed at a closer distance and younger age.
We found a higher incidence for both second and first primaries in males than in females in the overall population. In contrast, RRs for both second and first primaries were significantly higher in females than in male among the younger attained-age group. This is quite likely because female-specific cancers such as breast and uterine cervix are most prominent in the younger attained-age group, while stomach and colon cancers, which are not gender specific but typically show higher risks for their incidences in males than in female, are most prominent in the older attained-age group.
Radiotherapy and chemotherapy for the first primary might be associated with an increased risk of developing a second primary. (11) Our analysis did not control for treatment differences. However, the effect of treatment on a subsequent primary would be negligible in short-term MPC, because studies of treatment-associated risk for second primaries typically had at least a 10-15 year interval between the two tumors. (12, 13) Reports on large populations of patients, who have been exposed to cancer treatments in childhood, have shown that the cumulative probability of a second cancer can be quite low. (14) Also, other reports suggested that only about 1% of the long-term follow-up patients developed a second malignancy after treatment for the first primaries with an interval of 82-136 months. (15, 16) Thus, mechanisms other than those related therapy should be postulated for the development of the second primary in short-term MPC. In our study, 64.8% cases were short-term MPC, while only 16.4% cases were metachronous MPC with more than a 10-year interval. Our statistical analyses demonstrated a significant high incidence of short-term MPC in the survivors exposed at closer distance and younger age at the time of bombing. These results also provide evidence for the involvement of atomic bomb radiation in MPC among the survivors.
Our data suggest that the survivors, particularly for those who were exposed at a younger age, still have a high risk for cancers in multiple organs even at the present time. Although it is now 62 years since the atomic bomb explosions, we do not know the crucial mechanisms that can explain the continuously higher incidence of cancers in atomic bomb survivors for decades. It is noteworthy that according to our data base, the number of atomic bomb survivors living in Nagasaki city was 49,250 (39.4 % of Nagasaki A-bomb survivors) at the end of 2005. Furthermore, most of them were exposed as children in 1945. Thus, a higher risk of MPC, as a late effect of atomic bomb radiation, still persists in the survivors. We believe that further research on MPC in the survivors can contribute to an understanding of both radiation-associated carcinogenesis and a predisposition to cancers. 
